SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sangamo Therapeutics, Inc. SGMO
SGMO 0.426-7.6%Dec 1 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (104)1/16/2002 1:48:55 PM
From: nigel bates   of 368
 
Sangamo BioSciences Announces Agreement With Wyeth-Ayerst Laboratories

RICHMOND, Calif., Jan. 15 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO - news) today announced that it has signed a collaborative research agreement with Wyeth-Ayerst Laboratories, the pharmaceutical division of American Home Products Corporation (NYSE: AHP - news). Under the terms of this agreement, Sangamo will provide gene specific zinc finger DNA binding proteins, or ZFPs, to Wyeth-Ayerst for use in its internal research programs.
``More than 20 pharmaceutical and biotechnology companies have entered into agreements with Sangamo to use our Universal GeneTools(TM) ZFP technology platform for applications in pharmaceutical research,'' said Edward Lanphier, Sangamo's president and chief executive officer. ``These include collaborations focused on drug target validation, small molecule drug screening and model systems development.''
As the human genome is deciphered, the need to understand the role that individual genes play in various diseases has increased dramatically. Sangamo's Universal GeneTools(TM) are customized transcription factors designed to meet this growing need. Transcription factors are naturally occurring proteins that are found in virtually all organisms. By recognizing and binding to specific DNA sequences, they are able to turn genes ``on'' or ``off.'' Sangamo engineers a specific kind of transcription factor called zinc finger DNA binding proteins (ZFPs), to selectively bind to and regulate virtually any gene of interest...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News